PROYECTOS CONVOCATORIA PÚBLICA
Project PI16/00002
HVEM / BTLA / CD160 Y PD-L1/PD1 como dianas inmunoterapéuticas en el tratamiento de tumores hematopoyéticos
date_range
Duration: from 02 April 2019 to 30 September 2020
(18 months)
Finished
euro
23,740.70 EUR
Of National scope.
HVEM / BTLA / CD160 Y PD-L1/PD1 como dianas inmunoterapéuticas en el tratamiento de tumores hematopoyéticos
Researchers
Publications related to the project
Show by type2024
-
Assesment of Hypoderma infestation in a wild population of Cervus elaphus from mountains Atlantic ecosystems in southwestern Europe (Spain)
Veterinary Research Communications
2023
2022
-
The impact of CD160 deficiency on alloreactive CD8 T cell responses and allograft rejection
Translational Research
-
Differential Engraftment of Parental A20 PD-L1 WT and PD-L1 KO Leukemia Cells in Semiallogeneic Recipients in the Context of PD-L1/PD-1 Interaction and NK Cell-Mediated Hybrid Resistance
Frontiers in Immunology